These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 24067339

  • 1. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G, Pappacoda A, Dimatteo M, Scolari C, Riario-Sforza GG, Incorvaia C.
    Eur Ann Allergy Clin Immunol; 2013 Aug 01; 45(4):138-43. PubMed ID: 24067339
    [Abstract] [Full Text] [Related]

  • 2. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
    Manzotti G, Riario-Sforza GG, Dimatteo M, Scolari C, Makri E, Incorvaia C.
    Eur Ann Allergy Clin Immunol; 2016 Nov 01; 48(6):224-227. PubMed ID: 27852426
    [Abstract] [Full Text] [Related]

  • 3. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
    Pokladnikova J, Krcmova I, Vlcek J.
    Ann Allergy Asthma Immunol; 2008 May 01; 100(5):482-9. PubMed ID: 18517082
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct 01; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 10. Changing the route of immunotherapy administration: an 18-year survey in pediatric patients with allergic rhinitis and asthma.
    Pajno GB, Caminiti L, Passalacqua G.
    Allergy Asthma Proc; 2013 Oct 01; 34(6):523-6. PubMed ID: 24169060
    [Abstract] [Full Text] [Related]

  • 11. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P.
    Allergy; 2012 Mar 01; 67(3):302-11. PubMed ID: 22150126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy.
    Ventura MT, Carretta A, Tummolo RA, Buquicchio R, Arsieni A, Murgia N.
    Int J Immunopathol Pharmacol; 2009 Mar 01; 22(2):403-13. PubMed ID: 19505393
    [Abstract] [Full Text] [Related]

  • 16. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S, Karakoc-Aydiner E, Ozen A, Izgi AG, Tevetoglu A, Akkoc T, Bahceciler NN, Barlan I.
    J Allergy Clin Immunol; 2011 Oct 01; 128(4):808-815.e7. PubMed ID: 21641635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN, Cobanoglu N.
    Immunotherapy; 2011 Jun 01; 3(6):747-56. PubMed ID: 21668312
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.